Pfizer Retained Earnings (Accumulated Deficit) 2010-2025 | PFE
Pfizer retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $119.590B, a 1.42% decline year-over-year.
- Pfizer retained earnings (accumulated deficit) for 2024 were $116.725B, a 1.38% decline from 2023.
- Pfizer retained earnings (accumulated deficit) for 2023 were $118.353B, a 5.81% decline from 2022.
- Pfizer retained earnings (accumulated deficit) for 2022 were $125.656B, a 21.53% increase from 2021.